CN101732577B - Medicament for treating Meniere's disease - Google Patents
Medicament for treating Meniere's disease Download PDFInfo
- Publication number
- CN101732577B CN101732577B CN200810159725XA CN200810159725A CN101732577B CN 101732577 B CN101732577 B CN 101732577B CN 200810159725X A CN200810159725X A CN 200810159725XA CN 200810159725 A CN200810159725 A CN 200810159725A CN 101732577 B CN101732577 B CN 101732577B
- Authority
- CN
- China
- Prior art keywords
- weight portions
- medicament
- disease
- rhizoma
- medicine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Abstract
The invention provides a medicament for treating Meniere's disease, which comprises the following raw materials in proportion: dahurian angelica root, gambir plant, tribulus fruit, gentiana macrophylla, wrinkled gianthyssop herb, pinellia tuber, oriental waterplantain rhizome, atractylodes macrocephala, liquoric root, tall gastrodia tuber and the like. The medicament for treating Meniere's disease is characterized by reasonable compatibility, exact curative effect, good treatment effect and lasting medicinal effect, and effectively solves the problem of relapse of disease after treatment; and the medicament has short treatment time; patients can be treated after taking 10 doses of medicaments, and the relapse rate is low. The medicament not only has the definite curative effect on initial vertigo, but also has remarkable curative effects on relapsing and stuborn diseases, other types of vertigo as well as relapsing diseases that cannot be cured by traditional western medicine method nor by rhizoma gastrodiae pullus cum osse nigro soup in patients.
Description
Technical field
The present invention relates to a kind of medicine of treating Meniere, especially a kind of medicine that is the raw material for treating Meniere with pure Chinese medicine medicine.
Background technology
Meniere is claimed vertigo, auditory vertigo, hydrolabyrinth again, is a kind of commonly encountered diseases, frequently-occurring disease.The appearance of this disease symptoms is to be expanded by hydrops in the internal ear membranous labyrinth, oppresses due to the internal ear end organ.Mainly show as because of ictal dizziness appears in the position change, the sky changes sense, nausea and vomiting dizzyly, can follow tinnitus (being mostly a side) and dysacousis (deafness).Be repeatedly outbreak, whenever flu, be prone to bring out after drunk and tired, bring many inconvenience to patient's work, life, study.Traditional doctor trained in Western medicine is used tranquilizer (stable, phenobarbital, dimenhydrinate etc.), vasodilation (nicotinic acid, 654-2 hydrobromide injection, histamine phosphate, bendazol etc.), dehydrant (acetazolamide, hydrochlorothiazide etc.) and vitamins (B family, VC) treatment the earliest, and human 50% glucose Caledonia caine, vitamin B6 intravenous injection are then arranged.After the treatment, can only temporarily solve symptom, be prone to recurrence.After this, there is human Rhizoma Gastrodiae Gallus Domesticus to treat, the part patient obtained effect preferably, but still can't resolve the recurrence problem.
Summary of the invention
Technical problem to be solved by this invention is a kind of medicine of treating Meniere to be provided, to improve therapeutic effect, the generation that alleviates the recurrence problem.
The present invention is achieved in that a kind of medicine of treating Meniere, and it is made up of the following weight proportion raw material
The Radix Angelicae Dahuricae 10~15 weight portions
Ramulus Uncariae Cum Uncis 10~15 weight portions
Fructus Atriplicis Sibiricae 10~15 weight portions
Radix Gentianae Macrophyllae 10~12 weight portions
Herba Pogostemonis 10~12 weight portions
The Rhizoma Pinelliae 10~12 weight portions
Rhizoma Alismatis 12~15 weight portions
The Rhizoma Atractylodis Macrocephalae 12~15 weight portions
Radix Glycyrrhizae 9~12 weight portions
Rhizoma Gastrodiae 10~15 weight portions
Concha Haliotidis 13~17 weight portions
Pericarpium Citri Reticulatae 9~12 weight portions.
The medicine of this treatment Meniere, compatibility is reasonable, determined curative effect, therapeutic effect is good, and lasting medicine, efficiently solves the problem of treatment back recurrence.Treatment time is short, generally takes 10 doses and gets final product, and relapse rate is low, and therapeutic effect obviously is better than the Rhizoma Gastrodiae Gallus Domesticus Therapeutic Method of the present doctor trained in Western medicine common method of treatment and the traditional Chinese medical science.The present invention's medicine not only has definite curative effect to just sending out a vertigo, and to the obstinate case of outbreak repeatedly, with the patient of traditional doctor trained in Western medicine method treatment back unsatisfactory curative effect, use Rhizoma Gastrodiae Gallus Domesticus soup unsatisfactory curative effect or recurrence good curative effect is arranged also.And the dizzy symptom to other types also has curative effect preferably.
The specific embodiment
Further specify the present invention below.
During use, take by weighing each raw material by proportioning, after the mixing, decocte with water twice, its method is identical with the decocting method of existing water preparation, promptly adds decocting in water earlier one time, pours out medicinal liquid, in medicine, adds decocting in water again one time.The medicinal liquid of twice gained is mixed, sooner or later the secondary sub-service.10 days was 1 course of treatment.Also the fried equipment of available advanced person's Chinese medicine fried good after, process 20 parcel potus, each 1 bag, secondary is taken sooner or later.Add white sugar after also can medicinal liquid being concentrated, process granule, after drying, quantitatively take.
Traditional Chinese medical theory thinks that the pathogeny of Meniere is: stagnation of turbid phlegm in middle-JIAO, excessive rising of liver-YANG.The present invention's medicine merit is at drying dampness to eliminate phlegm, suppressing the hyperactive liver to relieve the wind syndrome, dizzy, the headache of specially disturbing on the dispelling the wind and dampness pathogens expectorant, all cards of vomiting and nausea.Rhizoma Pinelliae drying dampness to eliminate phlegm in the side, stopping nausea and vomiting by lowering the adverse flow of QI, Rhizoma Gastrodiae reduce phlegm endogenous wind stopping and end dizzyly, and two medicines share, for controlling the dizzy key medicine of wind-phlegm, so two to distinguish the flavor of be monarch drug with this.With the Rhizoma Atractylodis Macrocephalae, Radix Gentianae Macrophyllae, Rhizoma Alismatis, Pericarpium Citri Reticulatae is minister, invigorating the spleen to clear away damp pathogen.With the Rhizoma Pinelliae, Rhizoma Gastrodiae compatibility, damp eliminating is reduced phlegm, and it is good to end dizzy end dizzy benefit.Ramulus Uncariae Cum Uncis, Concha Haliotidis, Fructus Atriplicis Sibiricae are calmed down liver-yang, are assistant altogether with Herba Pogostemonis, the Radix Angelicae Dahuricae stomach function regulating of being amusing.Make with Radix Glycyrrhizae with in and transfer the property of medicine.All medicine phases 5, wind-phlegm disappears, and liver-yang is flat, dizzy spontaneous recovery.
Be the clinical effectiveness of the Drug therapy Meniere that shows the present invention, use traditional Western medicine drug, 100 examples to use Rhizoma Gastrodiae Gallus Domesticuss and 100 examples to use the cases of the present invention's Drug therapy Meniere, contrast with 100 examples.Carry out late result simultaneously and follow up a case by regular visits to, add up its relapse rate, carry out the anti-recurrence effect and judge.
The diagnostic criteria of Meniere: 1, just send out or outbreak, the position mobility repeatedly ictal, dizzy commentaries on classics property dizzy.2, follow more nauseating, the vomiting, with or without tinnitus, deafness.3, inspection is visible: horizontal nystagmus or rotatory spontaneous eye are quivered, tuning fork shows perceptive deafness.4, get rid of brain organic pathological changes or arrhythmia caused symptomatic dizzy outbreak.
Curative effect judging standard: recovery from illness, dizzy, tinnitus, deaf three classical symptom complete obiterations.Produce effects, dizzy, tinnitus classical symptom complete obiteration, deafness alleviates.Take a turn for the better, dizzy, tinnitus, deaf three classical symptoms all alleviate.Invalid, dizzy, tinnitus, deaf three classical symptoms all do not have and change or increase the weight of.
Test group: 100 examples, wherein male 50 examples, women 50 examples use the present invention's medicine to treat.Administrated method is with above-mentioned.
Matched group 1:100 example, wherein male 51 examples, women 49 examples, use traditional doctor trained in Western medicine method: stable 5-10mg (oral or injection), 654-2 hydrobromide injection 10-20mg,, VB
620mg adds 5% glucose injection 20ml, and vein is slow to be annotated.Once a day, totally 10 days.
Matched group 2:100 example, wherein, male 49 examples, women 51 examples.Get one of Rhizoma Gastrodiae 150g, Gallus Domesticus, after the Gallus Domesticus that lives was fallen to death, the boiled water QUMAO was excavated the five internal organs (cardiopulmonary reservation), and Rhizoma Gastrodiae is filled in the chicken tripe, boiled to eat Carnis Gallus domesticus and drink chicken soup, ate a chicken in two days, had a rest one day, ate second chicken again, had a rest one day again, ate the 3rd chicken.Eat three chickens altogether.
Above-mentioned respectively to organize situation such as case sex, age, the state of an illness suitable basically, and comparability is arranged.
Therapeutic effect sees the following form:
Group | Recovery from illness (routine number) | Produce effects (routine number) | Take a turn for the better (routine number) | Invalid (routine number) |
Matched group 1 | 60 | 30 | 10 | 0 |
Matched group 2 | 80 | 12 | 8 | 0 |
Test group | 96 | 4 | 0 | 0 |
Can find out that from last table the therapeutic effect of the present invention's medicine obviously is superior to each matched group.
After finishing back 3 months, half a year, 1 year, 3 years, 5 years, 10 years the course of treatment, pay a return visit respectively, judge relapse rate, data are percent %.The result sees the following form:
Group | Relapse rate after 3 months | Relapse rate after half a year | Relapse rate after 1 year | Relapse rate after 3 years | Relapse rate after 5 years | Relapse rate after 10 years |
Matched group 1 | 60 | 30 | 10 | 0 | 0 | 0 |
Matched group 2 | 57 | 25 | 18 | 0 | 0 | 0 |
Test group | 0 | 4 | 2 | 0 | 0 | 0 |
[0033]Show that through last table 3 months of matched group 1, the relapse rate of half a year are the highest, matched group 2 is lower slightly, and test group is minimum.The all recurrences in 1 year of two matched groups.Total relapse rate is merely 6% in the test group 1 year, explains that test group shows highly significant aspect anti-recurrence.
Embodiment 1
Take by weighing Radix Angelicae Dahuricae 10g, Ramulus Uncariae Cum Uncis 15g, Fructus Atriplicis Sibiricae 10g, Radix Gentianae Macrophyllae 12g, Herba Pogostemonis 10g, Rhizoma Pinelliae 12g, Rhizoma Alismatis 12g, Rhizoma Atractylodis Macrocephalae 15g, Radix Glycyrrhizae 9g, Rhizoma Gastrodiae 15g, Concha Haliotidis 13g, Pericarpium Citri Reticulatae 12g.After the mixing, decocte with water twice, its method is identical with the decocting method of existing water preparation, promptly adds decocting in water earlier one time, pours out medicinal liquid, in medicine, adds decocting in water again one time.The medicinal liquid of twice gained is mixed, sooner or later the secondary sub-service.
Embodiment 2
Take by weighing Radix Angelicae Dahuricae 15g, Ramulus Uncariae Cum Uncis 10g, Fructus Atriplicis Sibiricae 15g, Radix Gentianae Macrophyllae 12g, Herba Pogostemonis 12g, Rhizoma Pinelliae 10g, Rhizoma Alismatis 15g, Rhizoma Atractylodis Macrocephalae 12g, Radix Glycyrrhizae 12g, Rhizoma Gastrodiae 10g, Concha Haliotidis 17g, Pericarpium Citri Reticulatae 9g.After the mixing, decocte with water twice, its method is identical with the decocting method of existing water preparation, promptly adds decocting in water earlier one time, pours out medicinal liquid, in medicine, adds decocting in water again one time.The medicinal liquid of twice gained is mixed, sooner or later the secondary sub-service.
Embodiment 3
Take by weighing Radix Angelicae Dahuricae 10g, Ramulus Uncariae Cum Uncis 10g, Fructus Atriplicis Sibiricae 15g, Radix Gentianae Macrophyllae 10g, Herba Pogostemonis 12g, Rhizoma Pinelliae 10g, Rhizoma Alismatis 12g, Rhizoma Atractylodis Macrocephalae 12g, Radix Glycyrrhizae 9g, Rhizoma Gastrodiae 10g, Concha Haliotidis 13g, Pericarpium Citri Reticulatae 9g.After the mixing, decocte with water twice, its method is identical with the decocting method of existing water preparation, promptly adds decocting in water earlier one time, pours out medicinal liquid, in medicine, adds decocting in water again one time.The medicinal liquid of twice gained is mixed, sooner or later the secondary sub-service.
Embodiment 4
Take by weighing Radix Angelicae Dahuricae 15g, Ramulus Uncariae Cum Uncis 15g, Fructus Atriplicis Sibiricae 15g, Radix Gentianae Macrophyllae 12g, Herba Pogostemonis 12g, Rhizoma Pinelliae 12g, Rhizoma Alismatis 15g, Rhizoma Atractylodis Macrocephalae 15g, Radix Glycyrrhizae 12g, Rhizoma Gastrodiae 15g, Concha Haliotidis 17g, Pericarpium Citri Reticulatae 12g.After the mixing, decocte with water twice, its method is identical with the decocting method of existing water preparation, promptly adds decocting in water earlier one time, pours out medicinal liquid, in medicine, adds decocting in water again one time.The medicinal liquid of twice gained is mixed, sooner or later the secondary sub-service.
Claims (1)
1. a medicine of treating Meniere is characterized in that, it is made up of the following weight proportion raw material
The Radix Angelicae Dahuricae 10~15 weight portions
Ramulus Uncariae Cum Uncis 10~15 weight portions
Fructus Atriplicis Sibiricae 10~15 weight portions
Radix Gentianae Macrophyllae 10~12 weight portions
Herba Pogostemonis 10~12 weight portions
The Rhizoma Pinelliae 10~12 weight portions
Rhizoma Alismatis 12~15 weight portions
The Rhizoma Atractylodis Macrocephalae 12~15 weight portions
Radix Glycyrrhizae 9~12 weight portions
Rhizoma Gastrodiae 10~15 weight portions
Concha Haliotidis 13~17 weight portions
Pericarpium Citri Reticulatae 9~12 weight portions.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200810159725XA CN101732577B (en) | 2008-11-06 | 2008-11-06 | Medicament for treating Meniere's disease |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200810159725XA CN101732577B (en) | 2008-11-06 | 2008-11-06 | Medicament for treating Meniere's disease |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101732577A CN101732577A (en) | 2010-06-16 |
CN101732577B true CN101732577B (en) | 2012-06-27 |
Family
ID=42456945
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN200810159725XA Expired - Fee Related CN101732577B (en) | 2008-11-06 | 2008-11-06 | Medicament for treating Meniere's disease |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN101732577B (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105267699A (en) * | 2014-05-30 | 2016-01-27 | 蒋世芬 | Traditional Chinese medicine liquid preparation for treating Meniere disease |
CN104645296A (en) * | 2015-02-11 | 2015-05-27 | 金少举 | Traditional Chinese medicine for treating meniere vertigo |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1616013A (en) * | 2004-09-17 | 2005-05-18 | 鲁南制药股份有限公司 | Chinese medicine composition for treating dizziness and its preparing and quality control method |
CN101152454A (en) * | 2006-09-25 | 2008-04-02 | 张友年 | Chinese medicinal materials for treating dizziness |
-
2008
- 2008-11-06 CN CN200810159725XA patent/CN101732577B/en not_active Expired - Fee Related
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1616013A (en) * | 2004-09-17 | 2005-05-18 | 鲁南制药股份有限公司 | Chinese medicine composition for treating dizziness and its preparing and quality control method |
CN101152454A (en) * | 2006-09-25 | 2008-04-02 | 张友年 | Chinese medicinal materials for treating dizziness |
Non-Patent Citations (2)
Title |
---|
吕湘宾.近十年中医药治疗眩晕研究进展.《中医研究》.1995,第8卷(第01期), * |
李广浩等.中医药治疗眩晕研究近况.《中国中医急症》.2004,第13卷(第03期), * |
Also Published As
Publication number | Publication date |
---|---|
CN101732577A (en) | 2010-06-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN102048933A (en) | Chinese medicinal composition for treating infantile diarrhea and preparation method thereof | |
CN103536638A (en) | Medicament for treating gastrointestinal dysfunction and preparation method thereof | |
CN103735943B (en) | Pharmaceutical composition that a kind for the treatment of is had loose bowels and its production and use | |
CN103301267B (en) | Traditional Chinese medicine composition for treating hypertension and/or atherosclerosis and application thereof | |
CN102727817A (en) | Oral liquid for treating oral ulcer | |
CN102940785B (en) | Traditional Chinese medicine composition for treating vertigo | |
CN100528204C (en) | Medicament for treating children's infantile malnutrition symptom | |
CN103071138B (en) | Chinese medicinal composition for treating chronic gastritis as well as preparation method and application | |
CN101732577B (en) | Medicament for treating Meniere's disease | |
CN103341148A (en) | Traditional Chinese medicine preparation for treating infantile diarrhea | |
CN101708231A (en) | Blood pressure and blood fat reducing oral liquid used for improving sleep quality and preparation method thereof | |
CN104587299A (en) | Traditional Chinese medicine preparation for treating gastric and duodenal ulcers | |
CN101548993B (en) | Application of Japanese climbing fern spore in preparing lead excretion medicines or health products | |
CN103933453A (en) | Medicine composition for treating dyspepsia-induced damp stagnation | |
CN103845647B (en) | A kind of spleen fortune for the treatment of is lost the Chinese medicine of being good for type children anorexia | |
CN105233078A (en) | Traditional Chinese medicine composition for treating viral hepatitis | |
CN105311460A (en) | Traditional Chinese medicine for treating vascular neuralgia headache | |
CN103301368A (en) | Medicament for treating hyperactivity | |
CN103961391B (en) | A kind of pharmaceutical composition treating gastrointestinal neurosis | |
CN103230547A (en) | Traditional Chinese medicine for treating intractable hiccup | |
CN103007145A (en) | Traditional Chinese medicine composition for treating children rotavirus enteritis and preparation method of composition | |
CN106390081A (en) | Traditional Chinese medicine composition for treating damp-heat type stomachache | |
CN104707031A (en) | Traditional Chinese medicine composition for treating senile osteoporosis and preparation method thereof | |
CN104324164A (en) | Traditional Chinese medicine composition for nursing of cerebral concussion sequelae | |
CN102671052A (en) | Chinese medicinal composition for treating Meniere's syndrome |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20120627 Termination date: 20141106 |
|
EXPY | Termination of patent right or utility model |